Takeda Offer For Nycomed Seen Likely To Spur Other Japan M&As
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical's proposed buy of Nycomed of Switzerland is considered likely to inspire other Japanese drug makers to try mergers or acquisitions with foreign competitors